PRELUDE THERAPEUTICS INC
PRLDNASDAQ🏆 #2807 by market capEarnings Nov 5US Equity
$5.72▲ $0.43 (+7.52%)
Live1h▲ 1.2%
24h▲ 7.5%
7d▲ 26.0%
14d▲ 21.4%
30d▲ 29.0%
1y▲ 582.2%
🏦Market Cap
$456M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
23.0x
Expensive
Otter Score
64
Fair
Earnings
Q3 · 2026Reported 2026-08-11Earnings Per Share
Actual
-0.14
Expected
-0.20
beat
+28.80%
YoY +65.90%
Revenue
Actual
$5.70M
Expected
$5.70M
inline
+0.00%
Consensus estimates
Recent quarters
Q3 2026
-0.14
beat
Q2 2026
-0.13
beat
Q1 2026
-0.20
beat
Q4 2025
-0.26
beat